AI Advances in Healthcare: Drug Discovery, Diagnostics, and Disease Management - May 2026

Key points

• •In 2026, AI technology has enabled the identification of potential drug candidates for the rare Ebola virus, representing a critical breakthrough in antiviral drug development and offering hope for new treatments against this deadly condition.[News-Medical]
• •AI’s application in diagnostic imaging has advanced, with mammogram analysis now capable of revealing heart disease risks in women, expanding early detection beyond traditional breast cancer screening to cardiovascular health monitoring.[futurity.org]
• •The introduction of a stretchable AI skin patch in 2026 allows for real-time cardiac data analysis directly on the body within milliseconds, promising a revolutionary approach to continuous heart health monitoring with non-invasive wearable technology.[The Brighter Side of News]
• •AI-driven platforms are transforming clinical trial recruitment, exemplified by the May 2026 launch of a tool jointly developed by b.well Connected Health and myTomorrows, which enhances patient-trial matching accuracy and efficiency, potentially accelerating medical research.[HIT Consultant]
• •New AI diagnostic aids in medical imaging improve novice radiologists’ MRI reading accuracy by providing interpretative support, though experts see less benefit, highlighting AI's role in augmenting clinical training and decision-making in radiology.[AuntMinnie]
• •AI is increasingly being integrated into cardiac arrest care, enhancing diagnostic and intervention protocols which could significantly improve patient survival rates and emergency care effectiveness starting in 2026.[EurekAlert!]
• •Public health initiatives are leveraging AI for disease screening, such as the Cape Town Health Day event where over 100 people received AI-powered tuberculosis screenings, exemplifying AI’s growing importance in mass health diagnostics.[Knysna-Plett Herald]
• •Century Health raised $5 million in seed funding in 2026 after achieving a 97% accuracy rate in clinical data abstraction with its AI-powered platform, marking a substantial advancement in automated health data processing.[AI Insider]
• •AI applications in chronic disease management are expanding, as demonstrated by a newly developed AI tool in Malaysia that assists diabetes patients in maintaining optimal blood sugar levels, improving self-monitoring and disease control.[The Star | Malaysia]
• •Government-backed health research investments are supporting AI drug development projects, such as HLB Life Science R&D’s selection in 2026 by the Ministry of Health for an AI-driven oncology drug initiative, reflecting growing institutional endorsement of AI in medicine.[아시아경제]

Relevant articles